Cancer therapy fast-tracking welcomed

A new streamlined approach to approving targeted cancer therapies in Australia has been welcomed as a step towards the “future of cancer medicine”.

In a move that could dramatically improve patient access to care, a single review process has for the first time been used to list two lung cancer drugs on the PBS and their corresponding genetic tests on the MBS.

Previously, drugs and tests went through separate processes, leading to the situation where patients could be granted subsidised access to certain drugs but forced to fork out hundreds of dollars for tests to determine their